France : Cellectis secures a 40 million credit facility from the European Investment Bank to support its Research, Development and Innovation activities

Source :: Mena Report. December 30, 2022
Publication Year :: 2022
Abstract: Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it has entered into a 40 million credit facility agreement [...]

Subjects :: Banks (Finance) -- Innovations
Investment banks -- Innovations -- Finance
Company business planning
Company financing
Business, international
European Union. European Investment Bank -- Innovations -- Planning

Tools